Certara to Participate in Upcoming Investor Conferences
Certara (Nasdaq:CERT) announced participation in several investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (Nasdaq:CERT) announced participation in several investor conferences. Management will present at the RBC CM Global Healthcare Conference on Tuesday, May 19 at 9:30 a.m. ET, William Blair’s 46th Annual Growth Stock Conference on Tuesday, June 2, and the Jefferies Global Healthcare Conference on Wednesday, June 3 at 1:20 p.m. ET.
Live webcasts for the RBC and Jefferies events, plus 90-day replays, will be available on Certara’s investor relations website.
Details
News Market Reaction – CERT
On May 19, the first trading day after this news, CERT closed 0.66% above the previous close.
Data tracked by StockTitan Argus for the May 19 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- RBC CM Global Healthcare Conference
Date and Time: Tuesday, May 19 at 9:30 a.m. ET
- William Blair’s 46th Annual Growth Stock Conference
Date: Tuesday, June 2
- Jefferies Global Healthcare Conference
Date: Wednesday, June 3 at 1:20 p.m. ET
Live webcasts for the RBC and Jefferies conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.